Mouse CEA(Carcinoembryonic Antigen) ELISA Kit
To Order Contact Us: [email protected]
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RDR-CEA-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 693.6 |
Mouse Carcinoembryonic Antigen(CEA)ELISA Kit |
|||
QY-E20269 | Qayee Biotechnology | 96T | EUR 433.2 |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RD-CEA-Mu-48Tests | Reddot Biotech | 48 Tests | EUR 482.4 |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RD-CEA-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 663.6 |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RDR-CEA-Mu-48T | Reddot Biotech | 48T | EUR 355.22 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RDR-CEA-Mu-96T | Reddot Biotech | 96T | EUR 507.47 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
DL-CEA-Mu | DL Develop | 96T | EUR 330 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
DLR-CEA-Mu | DL Develop | 96T | EUR 346 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
SEA150Mu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 4138.42 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
SEA150Mu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 445.99 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
SEA150Mu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 585.7 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
SEA150Mu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 2275.63 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
4-SEA150Mu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mouse Carcinoembryonic Antigen (CEA) in samples from Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RD-CEA-Mu-48T | Reddot Biotech | 48T | EUR 338.3 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RD-CEA-Mu-96T | Reddot Biotech | 96T | EUR 483.3 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
ELISA kit for Mouse CEA (Carcinoembryonic Antigen) |
|||
E-EL-M0232 | Elabscience Biotech | 1 plate of 96 wells | EUR 640.8 |
Description: A sandwich ELISA kit for quantitative measurement of Mouse CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Mouse CEA (Carcinoembryonic Antigen) |
|||
ELK1130 | ELK Biotech | 1 plate of 96 wells | EUR 446.4 |
Description: A sandwich ELISA kit for detection of Carcinoembryonic Antigen from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
Human CEA(Carcinoembryonic Antigen) ELISA Kit |
|||
EH0090 | FN Test | 96T | EUR 628.92 |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml |
Human CEA(Carcinoembryonic Antigen) ELISA Kit |
|||
E39EH0090 | EnoGene | 96T | EUR 595 |
Rat Carcinoembryonic Antigen ELISA Kit (CEA) |
|||
RK03562 | Abclonal | 96 Tests | EUR 625.2 |
Human Carcinoembryonic Antigen ELISA Kit (CEA) |
|||
RK01085 | Abclonal | 96 Tests | EUR 625.2 |
Mouse Carcinoembryonic Antigen (CEA) CLIA Kit |
|||
20-abx491146 | Abbexa |
|
|
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
abx256792-96tests | Abbexa | 96 tests | EUR 801.6 |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
20-abx155329 | Abbexa |
|
|
Pig Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
abx361295-96tests | Abbexa | 96 tests | EUR 990 |
Carcinoembryonic Antigen (CEA) (Rat) ELISA Kit |
|||
E4742-100 | Biovision | each | EUR 836.4 |
Rat Carcinoembryonic Antigen(CEA)ELISA Kit |
|||
QY-E10372 | Qayee Biotechnology | 96T | EUR 433.2 |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
SEA150Ra-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 4358.33 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
SEA150Ra-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 464.1 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
SEA150Ra-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 611.57 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
SEA150Ra-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 2392.06 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
4-SEA150Ra | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Carcinoembryonic Antigen (CEA) in samples from Serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Carcinoembryonic Antigen (CEA) |
|||
MO47049 | Neuromics | 0.5 ml | EUR 418.8 |
Carcinoembryonic Antigen (CEA) |
|||
HY-P0277 | MedChemExpress | 5mg | EUR 1678.8 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
20-abx151022 | Abbexa |
|
|
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
abx250227-96tests | Abbexa | 96 tests | EUR 764.4 |
Sheep Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
abx364185-96tests | Abbexa | 96 tests | EUR 1111.2 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
DLR-CEA-Hu-48T | DL Develop | 48T | EUR 439.2 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Carcinoembryonic Antigen (CEA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
DLR-CEA-Hu-96T | DL Develop | 96T | EUR 558 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Carcinoembryonic Antigen (CEA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human carcinoembryonic antigen, CEA ELISA Kit |
|||
CSB-E04767h-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
Description: Quantitative sandwich ELISA kit for measuring Human carcinoembryonic antigen, CEA in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human carcinoembryonic antigen, CEA ELISA Kit |
|||
1-CSB-E04767h | Cusabio |
|
|
Description: Quantitative sandwich ELISA kit for measuring Human carcinoembryonic antigen, CEA in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Carcinoembryonic Antigen (CEA) (human) ELISA Kit |
|||
K4805-100 | Biovision | 100 assays | EUR 970.8 |
Description: Sensitive, Colorimetric Assay |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
LF-EK60048 | Abfrontier | 1×96T | EUR 814.8 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
PRB-5059 | Cell Biolabs | 96 assays | EUR 686.4 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
PRB-5059-5 | Cell Biolabs | 5 x 96 assays | EUR 2739.6 |
Carcinoembryonic Antigen (CEA) (Human) ELISA Kit |
|||
E4740-100 | Biovision | each | EUR 966 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RDR-CEA-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 438 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RDR-CEA-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 600 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RD-CEA-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 420 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RD-CEA-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 574.8 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RDR-CEA-Hu-48T | Reddot Biotech | 48T | EUR 303.24 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RDR-CEA-Hu-96T | Reddot Biotech | 96T | EUR 433.13 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
DL-CEA-Hu | DL Develop | 96T | EUR 282 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
DLR-CEA-Hu | DL Develop | 96T | EUR 296 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
SEA150Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 3470.83 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
SEA150Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 391.01 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
SEA150Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 507.16 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
SEA150Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 1922.21 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
4-SEA150Hu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Carcinoembryonic Antigen (CEA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RD-CEA-Hu-48T | Reddot Biotech | 48T | EUR 288.8 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RD-CEA-Hu-96T | Reddot Biotech | 96T | EUR 412.5 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
ELISA kit for Rat CEA (Carcinoembryonic Antigen) |
|||
E-EL-R0150 | Elabscience Biotech | 1 plate of 96 wells | EUR 640.8 |
Description: A sandwich ELISA kit for quantitative measurement of Rat CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Rat CEA (Carcinoembryonic Antigen) |
|||
ELK1297 | ELK Biotech | 1 plate of 96 wells | EUR 446.4 |
Description: A sandwich ELISA kit for detection of Carcinoembryonic Antigen from Rat in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
Rabbit Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
abx362811-96tests | Abbexa | 96 tests | EUR 990 |
Monkey Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
abx359529-96tests | Abbexa | 96 tests | EUR 990 |
Canine Carcinoembryonic Antigen(CEA)ELISA Kit |
|||
YLA0016CA-48T | Shanghai YL Biotech | 48T | EUR 502.5 |
Canine Carcinoembryonic Antigen(CEA)ELISA Kit |
|||
YLA0016CA-96T | Shanghai YL Biotech | 96T | EUR 618.75 |
Mouse Carcinoembryonic Antigen (CEA) Protein |
|||
20-abx065720 | Abbexa |
|
|
Mouse Carcinoembryonic Antigen (CEA) Protein |
|||
20-abx065722 | Abbexa |
|
|
CEA ELISA Kit| Rat Carcinoembryonic Antigen ELISA Kit |
|||
EF017615 | Lifescience Market | 96 Tests | EUR 826.8 |
Chicken Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
abx356418-96tests | Abbexa | 96 tests | EUR 990 |
carcinoembryonic antigen (CEA) (ABT-CEA) Mouse mAb |
|||
E2252673 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
ELISA kit for Human CEA (Carcinoembryonic Antigen) |
|||
E-EL-H0643 | Elabscience Biotech | 1 plate of 96 wells | EUR 640.8 |
Description: A sandwich ELISA kit for quantitative measurement of Human CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Human CEA (Carcinoembryonic Antigen) |
|||
ELK1196 | ELK Biotech | 1 plate of 96 wells | EUR 446.4 |
Description: A sandwich ELISA kit for detection of Carcinoembryonic Antigen from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA |
|||
LF-EK0161 | Abfrontier | 1×96T | EUR 723.6 |
ELISA kit for Human carcinoembryonic antigen,CEA |
|||
EK0179 | SAB | 96 tests | EUR 794.4 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human carcinoembryonic antigen,CEA in samples from serum, plasma, tissue homogenates and other biological fluids. |
CEA (Carcinoembryonic antigen) Antibody |
|||
E80807-10 | EnoGene | 100μl | EUR 225 |
Description: Available in various conjugation types. |
Human carcinoembryonic antigen (CEA) antigen |
|||
CEA15-N-100 | Alpha Diagnostics | 100 ug | EUR 270 |
Active Carcinoembryonic Antigen (CEA) |
|||
4-APA150Hu04 | Cloud-Clone |
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells |
Human Carcinoembryonic Antigen (CEA) OneStep ELISA Kit |
|||
EK7031 | BosterBio | 96wells/kit, with removable strips. | EUR 573.6 |
Human Carcinoembryonic Antigen (CEA) ELISA (4X96T) |
|||
LF-EK0162 | Abfrontier | 4×96T | EUR 2454 |
Mouse Carcinoembryonic Antigen ELISA kit |
|||
E03C0348-192T | BlueGene | 192 tests | EUR 1524 |
Description: A sandwich ELISA for quantitative measurement of Mouse Carcinoembryonic Antigen in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Carcinoembryonic Antigen ELISA kit |
|||
E03C0348-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A sandwich ELISA for quantitative measurement of Mouse Carcinoembryonic Antigen in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Carcinoembryonic Antigen ELISA kit |
|||
E03C0348-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A sandwich ELISA for quantitative measurement of Mouse Carcinoembryonic Antigen in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse carcinoembryonic antigen ELISA kit |
|||
E03C1598-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Mouse carcinoembryonic antigen in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse carcinoembryonic antigen ELISA kit |
|||
E03C1598-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Mouse carcinoembryonic antigen in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse carcinoembryonic antigen ELISA kit |
|||
E03C1598-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Mouse carcinoembryonic antigen in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Carcinoembryonic Antigen ELISA Kit |
|||
IMSCEAKT | Innovative research | each | EUR 548 |
Description: Mouse Carcinoembryonic Antigen ELISA Kit |
Carcinoembryonic Antigen (CEA) Antibody |
|||
20-abx270133 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
20-abx270165 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
20-abx270190 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
abx231576-100ug | Abbexa | 100 ug | EUR 577.2 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
20-abx175703 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
20-abx171571 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
20-abx171572 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
abx120020-1mg | Abbexa | 1 mg | EUR 944.4 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
abx022526-01ml | Abbexa | 0.1 ml | EUR 1328.4 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
abx020536-1mg | Abbexa | 1 mg | EUR 944.4 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
abx020540-1mg | Abbexa | 1 mg | EUR 944.4 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
abx020541-1mg | Abbexa | 1 mg | EUR 910.8 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
abx020542-1mg | Abbexa | 1 mg | EUR 828 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
abx020543-1mg | Abbexa | 1 mg | EUR 886.8 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
abx020544-1mg | Abbexa | 1 mg | EUR 828 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
abx020545-1mg | Abbexa | 1 mg | EUR 828 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
abx020546-1mg | Abbexa | 1 mg | EUR 828 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
20-abx102321 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
20-abx102322 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
20-abx102323 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
20-abx102324 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
20-abx128498 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
20-abx128499 | Abbexa |
|
|
CEA Antibody / Carcinoembryonic Antigen |
|||
V3527-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3527-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3527SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3597-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3597-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3597IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3597SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3598-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3598-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3598IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3598SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3599-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3599-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3599IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3599SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3716-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3716-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3716IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
|||
V3716SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
|||
V8890-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V8890-20UG | NSJ Bioreagents | 20ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V8890SAF-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9002-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9002-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9002IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9002SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9003-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9003-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9003IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9003SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9008-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9008-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9008IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9008SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9164-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9164-20UG | NSJ Bioreagents | 20ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9164SAF-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9318-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9318-20UG | NSJ Bioreagents | 20ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V9318SAF-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V4046-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V4046-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V4046SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V7069-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
CEA Antibody / Carcinoembryonic Antigen |
|||
V7069-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
CEA Antibody / Carcinoembryonic Antigen |
|||
V7069IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
CEA Antibody / Carcinoembryonic Antigen |
|||
V7069SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2444-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2444-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2444IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2444SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2445-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2445-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2445SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2446-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2446-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2446IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2446SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2447-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2447-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2447IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2447SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
RQ5159 | NSJ Bioreagents | 100ul | EUR 356.15 |
Description: This gene encodes a cell surface glycoprotein that represents the founding member of the carcinoembryonic antigen (CEA) family of proteins. The encoded protein is used as a clinical biomarker for gastrointestinal cancers and may promote tumor development through its role as a cell adhesion molecule. [RefSeq] |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2087-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: The COL-1 antibody recognizes proteins of 80-200kDa, identified as different members of the Carcinoembryonic Antigen family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. CEA antibody is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are positive) from pleural mesotheliomas (rarely or weakly positive). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2087-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: The COL-1 antibody recognizes proteins of 80-200kDa, identified as different members of the Carcinoembryonic Antigen family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. CEA antibody is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are positive) from pleural mesotheliomas (rarely or weakly positive). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2087IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: The COL-1 antibody recognizes proteins of 80-200kDa, identified as different members of the Carcinoembryonic Antigen family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. CEA antibody is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are positive) from pleural mesotheliomas (rarely or weakly positive). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2087SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: The COL-1 antibody recognizes proteins of 80-200kDa, identified as different members of the Carcinoembryonic Antigen family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. CEA antibody is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are positive) from pleural mesotheliomas (rarely or weakly positive). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2088-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2088-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2088IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2088SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2089-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2089-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2089IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2089SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2375-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2375-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2375IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2375SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2376-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2376-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2376CF488-100T | NSJ Bioreagents | 100 Tests | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2376IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V2376SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
|||
R20351-0.1ML | NSJ Bioreagents | 100ul | EUR 409 |
CEA Antibody / Carcinoembryonic Antigen |
|||
V8370-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Carcinoembryonic antigen (CEA) is a glycoprotein produced in colorectal cancer tissues. In normal adult tissue, CEA is expressed in the apical border and, to a lesser extent in the cytoplasm, of the columnar cells of colon, small intestine, stomach (surface epithelium, mucous neck cells and weakly in pyloric mucous cells), pancreatic ducts, secretory epithelia of sweat glands, squamous epithelial cells of the tongue, esophagus,uterine cervix, and urothelium. The CEA antibody is a useful aid for classification of adenocarcinomas, notably in the gastrointestinal tract, including colonic and pancreatic carcinomas. IHC results also aid in the classification of secretory meningiomas and medullary carcinoma of the thyroid. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V8370-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: Carcinoembryonic antigen (CEA) is a glycoprotein produced in colorectal cancer tissues. In normal adult tissue, CEA is expressed in the apical border and, to a lesser extent in the cytoplasm, of the columnar cells of colon, small intestine, stomach (surface epithelium, mucous neck cells and weakly in pyloric mucous cells), pancreatic ducts, secretory epithelia of sweat glands, squamous epithelial cells of the tongue, esophagus,uterine cervix, and urothelium. The CEA antibody is a useful aid for classification of adenocarcinomas, notably in the gastrointestinal tract, including colonic and pancreatic carcinomas. IHC results also aid in the classification of secretory meningiomas and medullary carcinoma of the thyroid. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V8370SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Carcinoembryonic antigen (CEA) is a glycoprotein produced in colorectal cancer tissues. In normal adult tissue, CEA is expressed in the apical border and, to a lesser extent in the cytoplasm, of the columnar cells of colon, small intestine, stomach (surface epithelium, mucous neck cells and weakly in pyloric mucous cells), pancreatic ducts, secretory epithelia of sweat glands, squamous epithelial cells of the tongue, esophagus,uterine cervix, and urothelium. The CEA antibody is a useful aid for classification of adenocarcinomas, notably in the gastrointestinal tract, including colonic and pancreatic carcinomas. IHC results also aid in the classification of secretory meningiomas and medullary carcinoma of the thyroid. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V8631-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: The CD66 (carcinoembryonic antigen, CEA, biliary glycoprotein I, BGP-1, CEACAM) immunoglobulin superfamily of genes encode cell adhesion proteins, which are expressed at higher levels in tumorous tissues than in normal tissues. The human CD66 gene family is a diverse set of glycoproteins of epithelial and hematopoietic lineage that comprises 29 genes, which map to chromosome position 19q13.2. CD66A, CD66B, CD66C, CD66D, CD66E and CD66F are the best characterized CD66 antigens, and CD66A-D expression upregulates on the surface of granulocytes upon stimulation. Certain CD66 family members mediate homotypic and heterotypic intercellular adhesion events. CD66E, also known as CEA, is a well known tumor marker and a heavily glycosylated GPI-linked cell surface molecule. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V8631-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: The CD66 (carcinoembryonic antigen, CEA, biliary glycoprotein I, BGP-1, CEACAM) immunoglobulin superfamily of genes encode cell adhesion proteins, which are expressed at higher levels in tumorous tissues than in normal tissues. The human CD66 gene family is a diverse set of glycoproteins of epithelial and hematopoietic lineage that comprises 29 genes, which map to chromosome position 19q13.2. CD66A, CD66B, CD66C, CD66D, CD66E and CD66F are the best characterized CD66 antigens, and CD66A-D expression upregulates on the surface of granulocytes upon stimulation. Certain CD66 family members mediate homotypic and heterotypic intercellular adhesion events. CD66E, also known as CEA, is a well known tumor marker and a heavily glycosylated GPI-linked cell surface molecule. |
CEA Antibody / Carcinoembryonic Antigen |
|||
V8631SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: The CD66 (carcinoembryonic antigen, CEA, biliary glycoprotein I, BGP-1, CEACAM) immunoglobulin superfamily of genes encode cell adhesion proteins, which are expressed at higher levels in tumorous tissues than in normal tissues. The human CD66 gene family is a diverse set of glycoproteins of epithelial and hematopoietic lineage that comprises 29 genes, which map to chromosome position 19q13.2. CD66A, CD66B, CD66C, CD66D, CD66E and CD66F are the best characterized CD66 antigens, and CD66A-D expression upregulates on the surface of granulocytes upon stimulation. Certain CD66 family members mediate homotypic and heterotypic intercellular adhesion events. CD66E, also known as CEA, is a well known tumor marker and a heavily glycosylated GPI-linked cell surface molecule. |
Carcinoembryonic Antigen (CEA ) Antibody |
|||
E12-76010 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
Carcinoembryonic Antigen (CEA) Antibody |
|||
E63C00301a | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
Carcinoembryonic Antigen (CEA ) Antibody |
|||
E76010-2 | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
Human Carcinoembryonic Antigen (CEA) ELISA (10X96T) |
|||
LF-EK0163 | Abfrontier | 10×96T | EUR 5380.8 |
Human Carcinoembryonic Antigen (CEA) ELISA (20X96T) |
|||
LF-EK0164 | Abfrontier | 20×96T | EUR 9369.6 |
Rat Carcinoembryonic Antigen (CEA) CLIA Kit |
|||
abx196777-96tests | Abbexa | 96 tests | EUR 990 |
Rat Carcinoembryonic Antigen (CEA) CLIA Kit |
|||
20-abx491147 | Abbexa |
|
|
Eukaryotic Carcinoembryonic Antigen (CEA) |
|||
4-EPA150Hu61 | Cloud-Clone |
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: 293F cell |
Mouse CEA(Carcinoembryonic Antign) ELISA Kit |
|||
EM0916 | FN Test | 96T | EUR 628.92 |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 37.5pg/ml |
Human Carcinoembryonic Antigen (CEA) CLIA Kit |
|||
abx196501-96tests | Abbexa | 96 tests | EUR 990 |
Human Carcinoembryonic Antigen (CEA) CLIA Kit |
|||
20-abx491145 | Abbexa |
|
|
CLIA kit for Rat CEA (Carcinoembryonic Antigen) |
|||
E-CL-R0108 | Elabscience Biotech | 1 plate of 96 wells | EUR 700.8 |
Description: A sandwich CLIA kit for quantitative measurement of Rat CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
Recombinant Carcinoembryonic Antigen (CEA) |
|||
4-RPA150Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli |
Recombinant Carcinoembryonic Antigen (CEA) |
|||
4-RPA150Hu02 | Cloud-Clone |
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli |
Recombinant Carcinoembryonic Antigen (CEA) |
|||
4-RPA150Hu03 | Cloud-Clone |
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli |
Recombinant Carcinoembryonic Antigen (CEA) |
|||
4-RPA150Hu04 | Cloud-Clone |
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli |
Recombinant Carcinoembryonic Antigen (CEA) |
|||
4-RPA150Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Carcinoembryonic Antigen expressed in: E.coli |
Recombinant Carcinoembryonic Antigen (CEA) |
|||
4-RPA150Mu02 | Cloud-Clone |
|
|
Description: Recombinant Mouse Carcinoembryonic Antigen expressed in: E.coli |
Recombinant Carcinoembryonic Antigen (CEA) |
|||
4-RPA150Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Carcinoembryonic Antigen expressed in: E.coli |
Carcinoembryonic Antigen(CEA) Mouse Monoclonal Antibody |
|||
38016-100ul | SAB | 100ul | EUR 302.4 |
Carcinoembryonic Antigen(CEA) Mouse Monoclonal Antibody |
|||
38016-50ul | SAB | 50ul | EUR 224.4 |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse) |
|||
4-PAA150Mu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA) |
Carcinoembryonic Antigen (CEA) Mouse Monoclonal Antibody |
|||
E038016 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
Carcinoembryonic Antigen/CEA Mouse Monoclonal Antibody |
|||
E12-084 | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
CLIA kit for Human CEA (Carcinoembryonic Antigen) |
|||
E-CL-H0492 | Elabscience Biotech | 1 plate of 96 wells | EUR 700.8 |
Description: A sandwich CLIA kit for quantitative measurement of Human CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
EASYStep Pro Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
RDEp-CEA-Hu-96T | Reddot Biotech | 96T | EUR 550 |
Description: serum and plasma. |
Carcinoembryonic Antigen (CEA) Antibody (PE) |
|||
20-abx270895 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (PE) |
|||
20-abx270927 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (PE) |
|||
20-abx270952 | Abbexa |
|
|
Rat Carcinoembryonic Antigen (CEA) Protein |
|||
20-abx652080 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (APC) |
|||
20-abx270663 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (APC) |
|||
20-abx270695 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (APC) |
|||
20-abx270720 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (FITC) |
|||
20-abx270431 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (FITC) |
|||
20-abx270463 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (FITC) |
|||
20-abx270488 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody Pair |
|||
20-abx370130 | Abbexa |
|
|
Mouse carcinoembryonic antign, CEA ELISA Kit |
|||
CSB-E13925m-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
Description: Quantitativesandwich ELISA kit for measuring Mouse carcinoembryonic antign, CEA in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Mouse carcinoembryonic antign, CEA ELISA Kit |
|||
1-CSB-E13925m | Cusabio |
|
|
Description: Quantitativesandwich ELISA kit for measuring Mouse carcinoembryonic antign, CEA in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Mouse carcinoembryonic antign(CEA)ELISA Kit |
|||
GA-E0111MS-48T | GenAsia Biotech | 48T | EUR 403.2 |
Mouse carcinoembryonic antign(CEA)ELISA Kit |
|||
GA-E0111MS-96T | GenAsia Biotech | 96T | EUR 640.8 |
Mouse carcinoembryonic antign,CEA ELISA Kit |
|||
YLA0648MO-48T | Shanghai YL Biotech | 48T | EUR 465 |
Mouse carcinoembryonic antign,CEA ELISA Kit |
|||
YLA0648MO-96T | Shanghai YL Biotech | 96T | EUR 600 |
Human Carcinoembryonic Antigen (CEA) Protein |
|||
20-abx065719 | Abbexa |
|
|
Human Carcinoembryonic Antigen (CEA) Protein |
|||
20-abx065721 | Abbexa |
|
|
Human Carcinoembryonic Antigen (CEA) Protein |
|||
20-abx065723 | Abbexa |
|
|
Human Carcinoembryonic Antigen (CEA) Protein |
|||
20-abx651474 | Abbexa |
|
|
Human Carcinoembryonic Antigen (CEA) Protein |
|||
20-abx166414 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody-HRP |
|||
E63C00302a | EnoGene | 100μg/100μl | EUR 295 |
Description: Available in various conjugation types. |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), PE |
|||
4-PAA150Mu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with PE. |
Carcinoembryonic Antigen (CEA) Antibody (Biotin) |
|||
20-abx271833 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (Biotin) |
|||
20-abx272619 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), APC |
|||
4-PAA150Mu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with APC. |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), Cy3 |
|||
4-PAA150Mu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with Cy3. |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), HRP |
|||
4-PAA150Mu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with HRP. |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), FITC |
|||
4-PAA150Mu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with FITC. |
Carcinoembryonic Antigen (CEA) Antibody-BIOTIN |
|||
E63C00303 | EnoGene | 100μg/100μl | EUR 295 |
Description: Available in various conjugation types. |
Carcinoembryonic Antigen (CEA) ELISA Kit (Human) : 96 Wells (OKBA00007) |
|||
OKBA00007 | Aviva Systems Biology | 96 Wells | EUR 396 |
Description: Description of target: ;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: 1.0 ng/ml |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse) |
|||
4-PAA150Hu04 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Carcinoembryonic Antigen (CEA) |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse) |
|||
4-PAA150Mu02 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Carcinoembryonic Antigen (CEA) |
Carcinoembryonic Antigen/CEA Monoclonal Antibody |
|||
EM1061-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Mouse Monoclonal antibody against Carcinoembryonic Antigen/CEA from Human/ Rat/ Mouse. This antibody is tested and validated for IHC |
Carcinoembryonic Antigen/CEA Monoclonal Antibody |
|||
EM1061-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Mouse Monoclonal antibody against Carcinoembryonic Antigen/CEA from Human/ Rat/ Mouse. This antibody is tested and validated for IHC |
CEA ELISA Kit| Mouse Carcinoembryonic Antign ELISA Kit |
|||
EF013507 | Lifescience Market | 96 Tests | EUR 826.8 |
Rat carcinoembryonic antigen ELISA kit |
|||
E02C1598-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Rat carcinoembryonic antigen in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat carcinoembryonic antigen ELISA kit |
|||
E02C1598-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Rat carcinoembryonic antigen in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat carcinoembryonic antigen ELISA kit |
|||
E02C1598-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Rat carcinoembryonic antigen in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Carcinoembryonic Antigen ELISA kit |
|||
E02C0348-192T | BlueGene | 192 tests | EUR 1524 |
Description: A sandwich ELISA for quantitative measurement of Rat Carcinoembryonic Antigen in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |